Answers are grounded in this paper and cite their sources.
The plasmatic levels of 1,3-beta-d-glucan (BDG) were >523 pg/ml in 4 children, 2 low-birth-weight neonates and 2 stem cell transplant recipients, with the following invasive fungal diseases (IFD) proven apart from this BDG test: 3 cases of Candida parapsilosis candidemias and 1 case of disseminated aspergillosis. The BDG test may be useful for identification of IFD in pediatrics.
No takes yet. Share an insight, caveat, or question.
Mularoni et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: